Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
GlaxoSmithKline
Essen Biotech
Hutchmed
Cellestia Biotech AG
Bayer
National Cancer Institute (NCI)